The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Rakuten Medical
Research Funding - AstraZeneca; Merck
 
Yael Flamand
No Relationships to Disclose
 
Harry Quon
Employment - Johns Hopkins Hospital
Leadership - Pistevo Health
Stock and Other Ownership Interests - Oncospace; Pistevo Health
Honoraria - Sanofi/Regeneron
Consulting or Advisory Role - Pinnacle Biologics; Tactile Medical
Research Funding - Toshiba; Vibrent Health
Patents, Royalties, Other Intellectual Property - Filed under Hopkins, we have several patents related to mobile informatics solutions
Other Relationship - EPIC (I)
 
Joaquin J. Garcia
No Relationships to Disclose
 
Gregory S. Weinstein
Patents, Royalties, Other Intellectual Property - Olympus
 
Umamaheswar Duvvuri
No Relationships to Disclose
 
Bert W. O'Malley
Patents, Royalties, Other Intellectual Property - Receive royalties from University of Pennsylvania via a licensed technology to Olympus Inc
 
Enver Ozer
No Relationships to Disclose
 
Giovana R. Thomas
No Relationships to Disclose
 
Wayne Koch
No Relationships to Disclose
 
Neil D. Gross
Honoraria - Intuitive Surgical
Consulting or Advisory Role - PDS Biotechnology; Sanofi/Regeneron; Shattuck Labs; Verb Surgical (Inst)
Research Funding - Genentech (Inst); MedImmune (Inst); Regeneron
Patents, Royalties, Other Intellectual Property - UpToDate
 
Richard Bryan Bell
Honoraria - Merck; Regeneron
Consulting or Advisory Role - Macrogenics
Speakers' Bureau - Merck; Regeneron
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
 
Nabil F. Saba
Honoraria - BioNTech; CUE Biopharma; Merck
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Blueprint Medicines; GlaxoSmithKline; Merck; Pfizer
 
Miriam Lango
No Relationships to Disclose
 
Rodrigo Bayon
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - ALX Oncology; CUE Biopharma; Debiopharm Group; Exelixis; Genentech/Roche; IO Biotech; Ipsen; Kura Oncology; Macrogenics; Maverick Therapeutics; Merck; Merck KGaA; Nanobiotix; PPD Global; Rakuten Medical
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - AstraZeneca; CUE Biopharma (Inst); Eisai; Exelixis (Inst); Genentech; Kura Oncology; Merck; Merck (Inst); Nektar; Rakuten Medical
Travel, Accommodations, Expenses - Debiopharm Group; Merck
 
Robert L. Ferris
Stock and Other Ownership Interests - Novasenta
Consulting or Advisory Role - Achilles Therapeutics; Aduro Biotech; Bicara Therapeutics; Bristol-Myers Squibb; EMD Serono; Everest Clinical Research; F. Hoffmann LaRoche; F. Hoffmann LaRoche; Genocea Biosciences; Hookipa Pharma; Instil Bio; Kowa Research Institute; Lifescience Dynamics; Macrogenics; Merck; Mirati Therapeutics; Novasenta; Numab; OncoCyte; Pfizer; PPD; Rakuten Medical; Sanofi; Seagen; VIR Biotechnology; VIR Biotechnology; Zymeworks; Zymeworks
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Novasenta; Tesaro